Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moleculin Biotech CS (NQ: MBRX )

2.670 -0.060 (-2.20%)
Streaming Delayed Price Updated: 1:04 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,803
Open 2.660
Bid (Size) 2.660 (2)
Ask (Size) 2.760 (4)
Prev. Close 2.730
Today's Range 2.650 - 2.760
52wk Range 2.115 - 15.75
Shares Outstanding 2,227,516
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insights Ahead: Moleculin Biotech's Quarterly Earnings
Via Benzinga
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-80.74%
-80.74%
1 Month
+3.69%
+3.69%
3 Month
+4.71%
+4.71%
6 Month
-41.70%
-41.70%
1 Year
-67.70%
-67.70%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Via ACCESSWIRE
MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
Via InvestorPlace
A Preview Of Moleculin Biotech's Earnings
Via Benzinga
Moleculin Biotech's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 22, 2024
Via Benzinga
Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
Via Benzinga
Earnings Scheduled For November 13, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.